ALPS Advisors’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

ALPS Advisors’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$228K	Buy	+117,096	New	+$239K	﹤0.01%	1148
2026 Q1	–	Sell	-112,451	Closed	-$448K	–	1091
2025 Q4	$448K	Buy	112,451 +961	+0.9%	+$4.25K	﹤0.01%	817
2025 Q3	$421K	Buy	+111,490	New	+$378K	﹤0.01%	893
2023 Q4	–	Sell	-60,400	Closed	-$79.7K	–	986
2023 Q3	$79.7K	Sell	60,400 -933	-2%	-$2.05K	﹤0.01%	974
2023 Q2	$183K	Buy	61,333 +6,659	+12%	+$21.4K	﹤0.01%	977
2023 Q1	$189K	Sell	54,674 -1,764	-3%	-$8.54K	﹤0.01%	986
2022 Q4	$236K	Buy	56,438 +11,301	+25%	+$42.8K	﹤0.01%	980
2022 Q3	$181K	Sell	45,137 -3,888	-8%	-$29.5K	﹤0.01%	1008
2022 Q2	$554K	Buy	+49,025	New	+$588K	0.01%	561

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ALPS Advisors's NBP Position: Q2 2026 in Review

ALPS Advisors opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q2 2026: 117,096 shares worth $228K. The stake represents ﹤0.01% of the portfolio and ranks #1148 among its holdings. This is a return to the name: ALPS Advisors previously reported a position in NBP as recently as Q4 2025.

ALPS Advisors first reported a position in NBP in Q2 2022 and has held it in 9 quarters since. The position peaked at $554K in Q2 2022. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

ALPS Advisors held 117,096 shares of NovaBridge Biosciences American Depositary Shares worth $228K as of Q2 2026.
NovaBridge Biosciences American Depositary Shares was a new ALPS Advisors position in Q2 2026.
NovaBridge Biosciences American Depositary Shares made up ﹤0.01% of ALPS Advisors's portfolio in Q2 2026, its #1148 holding.
ALPS Advisors first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2022 and has held it in 9 quarters since.
ALPS Advisors's NovaBridge Biosciences American Depositary Shares position peaked at $554K in Q2 2022.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on ALPS Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.